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Interest in Candida albicans as an opportunistic pathogen
has increased due to the complications that this microorganism
causes in cancer patients and other immunosuppressed
individuals. Recent advances in immunology have led to a
focus on cell mediated immunity which is of prime importance
in host resistance to infection. The present research was
initiated to study the effects of £. albicans extracts on
mouse splenic lymphocyte cultures obtained from inbred mice
infected with £. albicans. Aside from being a commensal
organism harbored in the oral, vaginal, and gastrointestinal
tract, £. albicans is a potential pathogen and causes different
disease states varying in severity from superficial to
disseminated infections. When the body*s immune responses
are depressed, the yeast can disseminate from mucosal foci.
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Several parameters were investigated in order to
arrive at a set of conditions for induction of delayed-type
hypersensitivity in mice and its measurement in the iri vitro
lymphocyte transformation assay. Both living yeast and
soluble antigen were used to induce delayed-type hyper
sensitivity. The conditions for tissue culture were varied
including lymphocyte concentration and source of serum
supplement. Other variables included the length of time in
culture and the type of medium and antibiotics employed.
The antigens of C» albicans included mannan polysaccharide
prepared in a new manner by protease digestion* and soluble
proteins. Other CJ. albicans extracts were tested such as a
ribosomal fraction. The results obtained helped to define
a set of conditions for lymphocyte transformation in mice
with special reference to the inbred AKR mouse.
It was of interest to determine the degree of lymphocyte
transformation elicited by Candida antigens in an inbred
mouse model. Based on the experience gained in the present
research, future attempts should be made to superimpose C.
albicans infection on leukemic mice and to measure their
lymphocyte responses with Candida extracts which are potent
elicitors of delayed-type hypersensitivity.
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For the past decade, microbiologists have intensified
research into the immunological response following infection
with zoopathogenic fungi. Progress in the development of
better means of immunodiagnosis is necessary in order to
provide timely and effective therapy. Candida albicans is
one of the fungi in this category and has as its habitat
the skin and mucosal membranes of warm-blooded animals and
man. In healthy individuals, it does not cause disease and
is referred to as a commensal organism. Under circumstances
of lowered host resistance, this fungus becomes an endogenous
opportunist and causes tissue invasion. In agar plate
cultures on peptone-glucose medium, Candida albicans grows
as a yeast giving rise to multilateral budding. Under
certain conditions such as a limited carbon source, elongated
cells occur in chains which are termed pseudohyphae because
the septa are not typical of the hyphae found in molds.
Another morphological characteristic which sets Candida
albicans apart from other yeasts is the occurrence of terminal
resting cells with thickened walls called chlamydospores
(Jansons and Nickerson, 19?0). In tissue infections both
yeast-like and pseudohyphal forms are found. Taxonomically,
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CJ. albicans is placed in the Fungi Imperfecti because no
sexual reproduction has been observed.
It is a commensal organism causing no apparent harm to
humans but is a potential threat to those persons whose
primary disease sets the stage for an opportunistic fungus
infection. Persons with diabetes or those receiving
prolonged antibacterial antibiotics, or cytotoxic drug
therapy of solid tumors and leukemia, and those receiving
immunosuppressive drugs to prevent allograft rejection of
transplanted organs are susceptible to C. albicans infection.
Due to the increase in cancer therapy and immunosuppressive
treatment, opportunistic fungus infections have become
frequent complications requiring prompt diagnosis.
The immune response to 0, albicans infection is twofold?
the humoral immune response is mediated through antibody
production by the B-lymphocytes in the presence of the
antigen, and the cellular immune response is mediated by
T-lymphocytes which undergo blast transformation to produce
lymphokines such as macrophage migration inhibitory factor,
and lymphotoxins which assist in the phagocytosis and
destruction of the target microorganism (Cooper and Lawton,
197*0. The two different functions, humoral and cellular
immunity, cooperate in a natural infection but the
differentiation of these responses can be demonstrated
experimentally with laboratory animals.
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One characteristic of cell-mediated immunity is the
delayed-type hypersensitivity reaction. This is a cellular
response which can be demonstrated when a suitable antigen
is injected into the skin. This response is also initiated
when the body tissues are invaded by microorganisms or are
exposed to allergenic substances. In the reaction produced
by the injection of antigen into the skin, lymphocytes and
macrophages infiltrate the site causing redness and swelling
which increases to a maximum at 2k hr. and persists at ^8 hr.
(Humphrey and White, 1971).
In man, several procedures are used to evaluate delayed-
type hypersensitivity including .in vitro methods, such as
the lymphocyte transformation assay which was the method
employed in this study. Lymphocyte transformation refers to
the morphological enlargement of small lymphocytes which
undergo transformation .in vitro to become larger lymphoblasts
and continue to divide to produce lymphokines (David, 1970).
This change occurs nonspecifically when lymphocytes are
exposed .in vitro to a mitogen such as phytohaemagglutinin;
it also occurs specifically in response to an antigen to
which the host is sensitized. Transformation is measured
indirectly by assaying the total %-thymidine incorporation
into DNA synthesis by lymphocytes held in short term tissue
culture. Lymphocyte transformation is impaired in patients
suffering from cancer, patients infected with viral diseases
such as measles, and endocrine disorders such as
hypoadrenalism (David, 1970). The antigen-induced in vitro
responses appear to be highly specific for a given antigen
and in most situations correlate closely with delayed
cutaneous hypersensitivity such as that produced by
tuberculin (Crowle, 1975).
Although infection with C,. albicans develops in diverse
clinical settings in man, the focus of this project was to
demonstrate Candida-induced delayed-type hypersensitivity in
a leukemic mouse model by injecting AKR mice with live
albicans yeast cells in an attempt to superimpose a Candida
infection on the mice in a leukemic state. The ability of
chemically different extracts of Candida to elicit lymphocyte
transformation was determined. Such studies in mice represent
a first step towards monitoring lymphocyte functions in man




Credit for the discovery of Candida albicans in a lesion
of oral thrush dated to Lagenbeck (1839) who described it in
one of the earliest accounts of a parasite in a human disease.
David Gruby (1842) described this fungus as "le vrai Muguet
des enfants." According to Rippon (1974) in 1853 Robin had
a great influence on the later generation of physicians and
recognized that the thrush fungus could become a systemic
pathogen as a terminal event of other illnesses. Wilkinson
in 1849 (as cited in Rippon, 1974) gave the first description
of vaginal candidiasis when he noted a profuse vaginal
discharge from one of his patients. The relationship
of £. albicans skin lesions due to subcutaneous infection and
disseminated disease was described as early as 1861. A
comprehensive review of the early history of candidiasis
is given by Rippon (1974).
A revival of interest in systemic candidiasis and candidal
endocarditis occurred after 1940 due to the use of broad
spectrum antibiotics which evoked a surge of research. The
results have demonstrated that the delicate ecosystem of
which £. albicans is a part, may become unbalanced allowing
an ordinarily nonpathogenic organism to disseminate from
mucosal foci. Joachim and Polayes (1940) described candidal
5
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endocarditis as a hazard of heroin infection. About the
same time, the association of candidiasis and steroid
therapy, imitmnosuppressive drugs, cytotoxic agents, and
immune defects became apparent. Presently, Candida albicans
is recognized as one of the most frequently encountered
fungal opportunists.
Today, research is carried out in several laboratories
to delineate the cellular immune response to Candida
albicans. Kirkpatrick et al. (1971) studied 3H-thymidine
incorporation into lymphocytes cultures to quantitate the
responses to phytohaemagglutinin and Candida albicans antigen
in healthy subjects and in chronic candidiasis patients.
Some healthy individuals with negative C. albicans skin tests
showed a small increment in DM synthesis when Candida extracts
were added to their lymphocytes .in vitro. Healthy skin test
positive persons produced marked responses with at least
fourfold increases in incorporation of ^H-thymidine. In a
study of seven patients with chronic candidiasis with respect
to host-defense mechanisms, Kirkpatrick .et al. (1971)
reported that there was no abnormality in the capacity of
polymorphonuclear leukocytes to ingest and kill C. albicans
or bacteria. In each patient the humoral immune response
was intact and titers of anti-Candida agglutinins and
precipitins in the serum were usually greater than normal.
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Abnormal cellular immune responses were common in patients
with chronic mucocutaneous candidiasis in the form of
negative skin tests to oidiomycin (a £. albicans culture
filtrate) and other Candida extracts. This observation was
especially striking since approximately 8Qfo of normal adult
subjects have positive delayed skin tests to £. albicans
(Kirkpatrick et al. 1971).
The utilization of chemical immunosuppressive agents to
treat cancer patients introduce infectious complications
caused by commensal microorganisms such as £. albicans.
Thirty percent of patients with neoplastic disease who were
diagnosed as having invasive candidiasis had lymphoma as
the primary disease and bOfa had solid tumors (Armstrong,
1973).
Invasive fungal diseases represent an important cause
of morbidity in patients whose host defenses have been
altered by their primary disease or immunosuppressive therapy.
The increasing incidence of complications in these susceptible
patients has been well documented in a recent review (Levine
et al. 1972) which stated that the major increase in fungal
complications was due to candidiasis, aspergillosis, and
mucormycosis, and that these infections were associated with
modern chemotherapy.
Candidiasis is the most frequent fungal complication in
patients with leukemia and lymphoma, but other Candida species
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have also been implicated. Likely portals of entry are the
mouth, gastrointestinal tract, urinary tract, and direct
blood stream inoculation by way of infusions or catheters.
Thrush, urinary tract infections, septicemia, gastrointestinal
ulcerations, meningitis, pneumonitis, and widespread
dissemination are the most common manifestations in patients
with leukemia and lymphoma who have candidiasis.
In order to develop a mouse model for C. albicans
infection, the existing literature on experimental murine
candidiasis was reviewed. Louria .et al. (I963) reported that
jC. albicans is pathogenic to White Swiss mice when live
yeast were injected intravenously. The kidney was the organ
of maximum involvement, and infection occurred in all animals
examined. Progressive infection was also seen in the brain
of most, but not in all animals. The other organs examined
by Louria and his associates passed through a stage of limited
infection which ultimately resolved.
The principal antigen of C_. albicans is marman, a
soluble polysaccharide composed of mannose units linked in
a linear<<-(i-> 6) backbone whose antigenic determinants
reside in the <*-(!-* 2) and <<-( 1-^3) linked mannohexaose
side chains (Suzuki and Sunayama, I968). In addition to
mannan, other components of the Candida cell have been induced
to make antibodies to as many as 60 proteins of a C. albicans
homogenate which could be demonstrated in rocket immuno-
electrophoresis (Axelson, 1973).
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Because of host susceptibility to C. albicans associated
with infectious complications in cancer patients, a leukemic
mouse model was designed to superimpose C, albicans infection
on the mouse in a leukemic state in order to determine the
degree of lymphocyte transformation elicited by Candida
allergens. The AKR mouse originated from a mouse strain of
non-inbred albino mice designated MA" and was claimed by the
breeder to yield many cancers. According to Gross (1970),
in 1930, Furth continued brother-sister mating of this "A"
mouse and after 25 generations, 70# of family AK mice
developed lymphatic leukemia upon reaching 1 year of age.
The strain was maintained at the Rockefeller Institute and
was designated AKR. In females the incidence of leukemia is
slightly higher varying from 71-85% while in males the
incidence of leukemia is 52-77%. AKR mice develop leukemia
at an average age of 8.8 months but onset varies from 5.5 to
10 months. Approximately 96% of these mice develop lymphoid
tumors of the thymus and spleen. Leukemic mice show evidence
of elevated white blood cell counts ranging from 23,000 to
125,000 white blood cells/mm3 with an average count of
55.000 wbc/mm3.
Ludvig Gross (1970) elucidated the viral cause of AKR
mouse leukemia in a series of experiments beginning with
transfer of leukemia by way of cells and later with cell-
free extracts. The pathogenicity of the "A" virus from AKR
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mice was first demonstrated by implantation of AK leukemic
cells into newborn C3H mice. Tumors appeared within 7-12
days after implantation and a few days later generalized
leukemia occurred followed by death. In 1937, leukemia was
experimentally induced in the C3H mouse by injection of a
single leukemic cell from the AK strain. The transmission
of AK mouse leukemia by injection of a cell-free filtrate
of leukemic cells to C3H mice, resulted in a delayed onset
of leukemia at 2.5 - 3*5 months. An acceleration of
leukemia was shown by injecting cell-free filtrates from
mature AK leukemic mice into newborn AK mice (90$ by 4.5
months). In I960, the passage of a cell-free filtrate from
AK leukemic cells in addition to serial cell-free passage
into C3H mice resulted in a virus which had higher leukemogenic
potency after 15 passages. Over 95$ of the C3H mice developed
leukemia in 2.5 to 3»5 months. The passage "A" virus which is
termed Gross leukemia virus can be stored for 12 months at
-70°C in sealed glass ampoules up to 2 yr. The current
picture of mouse leukemia is that the mother passes the virus
to the offspring .in utero. During early stages of growth the
mouse is not diseased but some event in maturation occurring
at about 8 months causes the RNA virus to bud from the
membranes of cells in the thymus and spleen. The resulting
lymphosarcoma spreads and a diffuse infiltrate of leukemic
cells is found in other internal organs such as the liver,
culminating in a lymphocytic leukemia.
11
Since leukemic patients who are being treated with
cytotoxic and immunosuppressive drugs are vulnerable to
candidiasis, the studies of antigen stimulation of mouse
lymphocytes has implications for the development of a vaccine.
If some subcellular component has the ability to increase
host resistance perhaps a vaccine would be practical.
Delayed-type hypersensitivity reactions in mice have
only recently been elicited regularly by skin or foot pad
tests in mice (Kong et al. 1966). The variation in results
may be related to the different mouse strains or to
variations in sensitization and testing procedures. It may
also be due to the dose of antigen used to elicit the
reaction.
Kong et al. (1966) and his associates tried to demonstrate
delayed hypersensitivity in albino mice by injecting 0.1 to
50 ug of BCG (Bacille Calmette Guerin) vaccine subcutaneously
into these mice. The two test antigens, tuberculin and
purified protein derivative, were injected into the foot pad
to test the capacity of the mice to exhibit a delayed type
hypersensitivity reaction. Although the initial injection
produced moderate swelling and erythema lasting up to 2k hr.,
only tuberculin elicited a delayed response in the sensitized
mice. The reaction was visible from 6 to 48 hr. with maximal
induration at 18 to 24 hr. after injection.
CHAPTER III
MATERIALS AND METHODS
lt Candida albicans Antigen Preparations
A. Pronase-digested Mannan
The starting material, mannan polysaccharide was prepared
by the method of Peat et al. (I96l) and was obtained from
a supply at the Mycology Division. Center for Disease Control,
Atlanta, Georgia. Mannan, 500 mg, was dissolved in 20 ml of
Tris-HCL buffer, 0.02M, PH 7.6, also containing cycloheximide,
50 pg/mlj chloramphenicol, 25 jug/ml? and CaCl2, 5 x lcT^M. To
this was added 4 mg of Streptomyces griseus alkaline protease,
Pronase (Calbiochem, CB grade). This solution was incubated
in a 37°C water bath, and at various intervals 10, 25, and
50 pi aliquots were sampled for free amino acids with ninhydrin,
with respect to an L-leucine standard (Narahashi, 1970).
Samples to be tested were added to distilled water to give a
final volume of 1 ml. Ninhydrin reagent (1 ml) and 0.5 ml
citrate buffer, 0.02M. PH 5.0 (1 ml) were added and the tubes
were heated in a boiling water bath for 15 min. The samples
were then cooled in an ice bath and diluted with 3 ml of 60f,
ethanol. Samples then were vortexed and kept at ambient
temperature for 10 min. and the optical density was measured
at 570 nm in a model 25 Beckman spectrophotometer. After 7 hr.
of digestion with pronase there was no further release of
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amino acids and the reaction was terminated by heating the
PDM in a boiling water bath for 10 min.
An ion exchange column containing the diethylaminoethyl
(DEAE) Sephadex A-25 was prepared for the PDM. Approximately
50 g of DEAE Sephadex A-25 (Pharmacia Fine Chemicals,
Piscataway, New Jersey) was swollen in 0.01M cold Tris-HCL
buffer, pH 7*6, and a 3 x 15 cm column was poured and
equilibrated with this buffer. A peristalic pump (Sage
Instruments Model 375 A) was connected to the column to give
a controlled flow rate of 25 ml/hr. The PDM was applied drop-
wise to the column with a pasteur pipet in order to avoid
disturbing the Sephadex gel bed surface. The column then
was allowed to elute until the sample had entered the gel
matrix. Fractions of 5 ml were collected and monitored with
an ultraviolet flow analyzer (Uvicord II LKB - Produkter,
Bromma, Sweden) at 280 nm. The fractions were screened for
carbohydrate content employing the phenol-sulfuric acid method
(Hodge and Hofreiter, 1962). First, samples of 1 ml were
pipetted into 18 x 150 mm lint-free test tubes. Then, 1 ml
of 5% phenol was added and the contents were gently vortexed.
Next, concentrated sulfuric acid (5 ml) was carefully added
to each tube, gently vortexed, and allowed to react at room
temperature for 20 min. Due to the heat generated on addition
of acid, gloves and goggles were worn as a precaution. Optical
density readings then were determined with a Klett-Summerson
colorimeter (Klett Manufacturing Company, New York) equipped
with a blue (No. ^2) filter. Fractions 6 through 11 were
observed to contain carbohydrate, and these fractions were
pooled (25 ml) and concentrated by molecular filtration to
8 ml with a Pellicon Millipore Molecular Filtration Device
(Millipore Corporation, Bedford, Mass.). This device (a 100
ml cell) was equipped with a PSAC membrane having a nominal
molecular weight limit of 1000. The concentrated solution
containing PDM was dialyzed versus 6 liters of deionized
water in the cold overnight and then was lyophilized. The
dry powder was stored at -40°C.
B. Candidal Proteins
The starting material for this antigen preparation was a
70?o saturated ammonium sulfate precipitate of a 100,000 x g
supernate obtained by mechanical disruption of Candida albicans
.218JA yeast cells. This candidal extract then was subjected
to affinity chromatography on Concanavalin A insolubilized
on agarose beads (Ellsworth e£ al. 197*0. A 0.9 x 18 cm
column of Concanavalin A-Sepharose (Pharmacia Fine Chemicals,
Piscataway, New Jersey) was equilibrated with 0.02M Tris-HCL
buffered saline, pH 7*2, containing 1 x 10"^M CaCl2 and 1 x
10"3M MnCl2. A 200 mg sample of the candidal extract was
dissolved in Tris-HCL buffered saline, pH 7.2, placed onto the
column and eluted at 10°C at a flow rate of 15 ml/hr. and the
column effluent was monitored with the aid of an ultraviolet
analyzer. Fractions of 3 ml were collected and screened for
protein content using the Lowry et al. (1951) protein
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determination method. Fractions 6 through 10 were pooled,
dialyzed overnight versus 6 liters of phosphate buffered saline
and then lyophilized. The sample then was rechromatographed
on a second Concanavalin A-Sepharose column to assure
complete removal of mannan polysaccharide. The extract, after
the second passage through the affinity column was dialyzed,
lyophilized and stored at -4o°C. The preparation was
referred to as candidal soluble proteins.
C. Formalinized Whole Yeast Cells
Formalinized whole yeast cells were prepared by combining
an equal volume of Candida albicans 3181A cells with 0.5%
formaldehyde in 0.85% sterile saline. After mixing, this
suspension was allowed to stand overnight in the cold. The
cells were centrifuged at 5000 rpm for 10 min. and washed
three times with distilled water, lyophilized, and plated on
Sabouraud's agar to verify that no living cells were present.
D. Ribosomal Preparation
Candidal ribonuclear proteins were prepared in the
following manner, 20 g of wet packed weight Candida albicang
32ML cells (48 hr. old) were homogenized in a Braun cell
homogenizer cooled with liquid C02 (Palmiter, 1971». This
homogenate was centrifuged at 5000 x g for 15 min. to remove
cell walls. The supernate (4? ml) then was centrifuged at
20,000 x g for 30 min. yielding a total volume of k2 ml Post-
Mitochondrial Supernate (PMS). An equal volume of Triton X
100 detergent-Mg++ (0.02M) in Tris buffer was added to the
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42 ml PMS in a flask and mixed with a magnetic stirrer at
0°C for 2 hr. Aliquots of 10 ml of this suspension were
layered over 6 ml of a 0.5M sucrose cushion (in 25 mM Tris-
HCL, -25 mM NaCl-100 mM MgCl2, pH 7.5) in a 300 ml poly
carbonate oak ridge tube. This discontinuous gradient was
centrifuged (Sorvall RC2B) at 27,000 x g for 20 min. and then
the ribosome pellets were collected and stored at -40°C.
2t Immunization of Mice With Adjuvant
For one series of experiments, mice were immunized
with Candida antigen in complete Freund adjuvant (Herbert,
1967). The oil phase was made by mixing paraffin oil, Markol
52 (N.F.), and the emulsifier, mannide monooleate (Arlacel A)
in the following proportions! Markoli Arlacel A=65%O5% vol./
vol. This solution was sterilized in an autoclave for 40 min.
at 15 1b. pressure. The mycobacterial component of the
adjuvant then was combined with oil phase. Heat-killed and
dried mycobacteria, 100 mg, (Mvcobacterlnn, tuberculous var.
hfiminis strain DT 612) was placed in a small mortar and 10 ml
of the oil-arlacel was added dropwise with firm but not
extreme maceration. The heat-killed tubercle bacilli were a
gift of Dr. Merle Selin. Center for Disease Control, Atlanta,
Georgia.
A Virtis homogenizer equipped with a small blade was
used to emulsify the oil-in-water mixture. About 2 ml of oil-
arlacel was placed in a 10 ml beaker immersed in an ice bath.
The antigen was added in 0.5 ml aliquots with 10 sec. intervals
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of homogenation. Care was taken to prevent aerosol formation
and to protect eyes. The antigen in adjuvant was instilled
into the mouse peritoneal cavity in the following wayi the
adjuvant was aspirated with a 2 ml syringe and a 15 gauge
needle, due to its viscosity, then a 25 gauge needle was used
for injection. The abdominal surface of each mouse was
wiped with an alcohol sponge before injecting the adjuvant,
and then the needle was gently inserted through the skin at a
30° angle. When the needle could be felt between the finger
tips, the syringe was slightly retracted and pushed down to
pierce the peritoneum. The adjuvant was injected in 0.2 ml
amounts. Care was taken to autoclave needles and syringes
after each injection and gloves were worn to prevent
accidental self-sensitization.
3> Preparation of Candida albicans for Mouse Sensitization
A 72 hr. culture of Candida albicans 3181A (Mycology
Division, Center for Disease Control, Atlanta, Georgia) grown
on Sabouraud's medium was the source of the cells used to
sensitize the mice. Approximately k ml of sterile saline was
added to the culture which was then gently shaken to free the
Candida yeast cells from the agar slant, forming a dense
suspension. Serial dilutions for cell counting were produced
by adding 0.1 ml of undiluted cell suspension to 0.9 ml of
0.85$ sterile saline and then two-fold dilutions up to lil60
were prepared. Crystal violet was added to stain the cells to
increase visibility. Diluted cells were counted in a
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hemocytometer chamber (American Optical, Buffalo, New York)
with the kOx objective of a binocular microscope (Carl Zeiss).
From this method it was possible to determine the volume
containing a suitable number of cells which then were diluted
in a 0.85% sterile saline to give a final concentration of
1 x 105 cells/ml.
**' IntravenQus Injection of Mice With fiandida alh1r»n«
Male AKR mice (6-9 months old) were injected intravenously
with live Candida albicans yeast cells. Before injection, the
cage containing mice was placed under a 60 watt lamp until
the veins of the mice became prominent (about 10 min.). A
sterile 1 ml syringe with a 2? gauge hypodermic needle (Sherwood
Medical Industries, Deland, Florida) was used to inject a dose
of 1 x lo4 Candida albicans 3181A yeast cells in a volume of
0.1 ml into the mouse tail vein. For each experiment, 6 mice
were injected and returned to a labeled cage indicating the
dose received, the date of injection and the date of sacrifice.
Each group was sacrificed at 21 days post-infection. To
prevent accidents to laboratory workers, gloves were worn
during handling of mice injected with live Candida albicanji
1181A yeast cells and discarded syringes were autoclaved. To
avoid accidental mixing of mice on different schedules, mouse
fur was dyed with either picric acid, safranin. or crystal
violet. During the course of the sensitization period, the
mice were closely observed for signs of illness. Purina
19
laboratory chow and water were available to these mice ad
libitum. The animal room temperature was maintained at
22°C.
5* Preparation of Splenic Lymphocytes
A. Removal of the Spleen
The mice were sacrificed 21 days after injection of live
Candida albicans 3181A yeast cells. One day prior to
sacrifice, all equipment necessary for preparing the spleen
cell suspension was thoroughly cleaned and autoclaved. Before
collecting the spleens, the pH of the suspension medium
(RMPI l6kO) was checked and adjusted if necessary (Roswell
Memorial Park Institute medium 16^0j Microbiological Associates,
Bethesda, Maryland). The desired pH of the medium was 7.3
and adjustments were made with either 0.1 N HCL or 7% NaHCO-,.
The mice were anesthetized with ether in a 500 ml specimen
jar and then bled by cardiac puncture. Blood samples were
collected from each mouse with a 1 ml sterile syringe coated
with 0.1$ heparin solution. This solution was prepared by
dissolving 25 mg of heparin in 25 ml of 0.85% sterile saline
and was filter sterilized through a 0.45 yum porosity filter
(Swinnex 25, Millipore Corporation, Bedford, Mass.). The
peripheral white blood cell (wbc) count with respect to a
norman human standard (8800 wbc/mm^) was determined with a
Coulter Particle Counter (Coulter Electronics Incorporated,
Hialeah, Florida). Thin blood smears were also stained with
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Wright*s stain and observed for the presence of leukemic
cells.
The spleens of the mice were aseptically removed with
sterile forceps and scissors. Each mouse was pinned to a
dissection board after collecting blood samples and the
abdominal surface was moistened with 7Ofo ethanol. A midline
incision was made through the epidermis exposing the peritoneum
and this membrane was rinsed with 70$ ethanol. A different
pair of forceps and scissors were then used to enter the
abdominal cavity. The spleen was removed and placed in 5 ml
of RPMI 16^0 medium contained in individual 50 ml beakers
immersed in crushed ice. The mice were examined post-mortem
by Dr. Francis Chandler of the Center for Disease Control
histopathology laboratory for evidence of leukemia and of
Candida albicans infection of the liver, kidney, and lymph
nodes.
B. Processing of Spleen Cells for the Lymphocyte
Transformation Assay
The spleens were removed from the beakers and placed on
a stainless steel sieve (Newark Wire Cloth Company, Newark,
New Jersey) 3 in. in diameter and ASTM standard 30 mesh
(American Society for Testing Materials) with an opening size
of 250 /ira. Each sieve was placed in a petri dish, 15 mm deep
x 150 mm in diameter, and immersed in an ice bath. Approximately
5 ml of RPMI 164-0 medium was added to the petri dish to keep
the spleen and sieve moist. Curved tip forceps and
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dissecting scissors were used to clip the spleens into fine
fragments. With a gentle grinding motion, the rubber tip end
of a 10 cc syringe plunger was used to gently macerate the
spleen fragments forcing them through the sieve. The sieves
were washed with an additional 5-10 ml of RMPI 1640 medium to
quantitatively transfer the remaining spleen cells. After
use, the sieves were disinfected and prepared for the next
experiment by soaking them in 2% Amphyl disinfectant (Amphyl
National Laboratories, Montvale, New Jersey) for 1 hr. and
removing the tissue debris by a thorough rinse in tap water.
Next, the sieves were soaked overnight in a Ifo solution of
nonionic detergent (7X, Linbro Chemical Company, New Haven,
Connecticut) followed by rinsing and steam cleaning in
deionized water in a small instrument sterilizer, then dried,
packed in aluminum foil, and autoclaved.
The spleen cell suspension was then drawn into a 10 cc
syringe with a 21 gauge needle and expelled into a labeled,
chilled, 50 ml erlenmeyer flask. Each flask was marked A, B,
C, D, E, and F respectively to correspond with the spleen of
the mouse being processed. An additional 5-7 ml of RPMI I6ko
medium was added to the suspension before transferring it to
a 16 x 125 mm test tube. All suspensions were centrifuged
at 411 x g for 20 min. at 10°C (CRU-5000 centrifuge,
International Equipment Company, Needham Heights, Mass.).
The supernate was aspirated with a sterile pasteur pipet
connected to a vacuum trap and the cells then were washed a
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second time with RPMI 1640 medium prior to the red blood cell
lysis stage. The red blood cells were lysed with hemolytic
solution which required three stock solutions to prepare the
final lysing fluid. The components of the reconstituted
working solution contained 2O# component A, % component B,
5% component c, and ?0$ sterile distilled water. The
ingredients of the hemolytic solution consisted of the
following in grams/liter. Solution A, NH^Cl, 35.0? KCL,
9.85? Na2HP0v 0.59? KH2P0v 0.119; glucose, 5.0? phenol
red, 0.05? gelatin (Difco), 25.0. Solution Bi MgClp #
6H20, 4.2? MgS04 ' ?H20, 1.4? CaClg, 3.4. Solution C.
NaHCO-j, 22.5. Each of these components (A, B, and C) were
sterilized in an autoclave at 15 1b. of pressure for 15 min.
The components were combined in the appropriate proportions
prior to use and filter sterilized with a 100 ml filter unit
over a 0.45 um porosity membrane (Nalge-Sybron Corporation,
Rochester, New York). Solution A was susceptible to microbial
growth and solution C was susceptible to decomposition by
contact with air. Because of these factors, they were
dispensed in test tubes in 10 ml portions and stored in the
cold until ready for use. The pH was checked before use and
adjustments were made if necessary to obtain a final pH of
7.2-7.4 (horning Digital 110 Expanded Scale pH Meter, Medfield,
Mass.).
About 4 ml of chilled hemolytic solution was added to
each 16 x 125 mm test tube of mouse splenic lymphocytes
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suspension and was allowed to react for 5 min. at room
temperature. Then 5 ml of RPMI 164-0 medium was added to
each tube which were then centrifuged at 4-11 x g for 5 min.
and the supernates aspirated with a sterile pipet connected
to a vacuum trap. The sedimented lymphocytes were resuspended
and washed with two additional 5 ml portions of RPMI 164-0
medium to remove all traces of NH^Cl and hemoglobin. After
the last wash, the cells were resuspended in 4- ml of RPMI 164-0
medium.
6. Reconstitution of the Tissue Culture Medium
The tissue culture medium was prepared as a 2 x stock
solution just prior to each experiment. This solution consisted
of RPMI 1640 medium (Microbiological Associates, Bethesda,
Maryland) 200 ml; L-glutamine, 0.06^; penicillin, 200 ug/mlj
streptomycin, 100 fig/ml; and fetal calf serum 10# (Rehatuin
Unfiltered, Reheis Chemical Company). Fetal calf serum was
stored in 20 ml amounts and after thawing was heat-inactivated
at 56°C for 30 min. After combining medium, serum, penicillin,
and streptomycin, this basal medium was filter sterilized over
a 0.4-5 um porosity membrane in a 100 ml Nalge filter unit.
Mycostatin (nystatin, Squibb) a polyene macrolide antifungal
antibiotic, was prepared as a 100 x stock suspension (20 mg/
100 ml) in sterile distilled water and frozen in aliquots
until needed. The final desired concentration was 2 ug/ml.
Because of its insolubility, nystatin was added after filter
sterilization of the basal medium.
2k
Splenic lymphocytes were washed as described above and
for the last wash they were resuspended in RPMI !6kQ medium
at a concentration of 1 x 10 lymphocytes/ml. Then 0.5 ml
of this cell suspension was pipetted in each 13 x 100 mm
glass screw cap tissue culture tube followed by 0.5 ml of
the appropriate tissue culture medium containing antigen.
7. Dosage of Candida albicans Antigens and Mitogen for
Tissue Culture
A total of 5 antigens and 1 mitogen were employed in the
lymphocyte transformation assays. The mitogen chosen was
phytbhaemagglutinin and was operated throughout the research
period as a control. The antigens included were candidal
proteins, Candida pronase-digested mannan, formalinized whole
yeast cells, Candida ribonuclear proteins, and peptidoglucomannan
(PGM). Phytohaemagglutinin (PHA-P, Difco) was prepared in the
following manneri each vial from the manufacturer contained
about 75 mg of active haemagglutinin and was dissolved in 5 ml
of sterile distilled water giving an agglutinin concentration
of 15 mg/ml. It was stored at -20°C in 0.5 ml aliquots,
because freeze-thawing is injurious to the activity. For the
preparation of 25 ml of a 2 x stock of PHA in RPMI 1640 medium,
750 mg of phytohaemagglutinin was required and to obtain this
desired concentration, 50 ul of 15 mg/ml stock solution was
added to 25 ml of medium. An equal volume of this solution
when added to an appropriately diluted cell suspension gave a
final dose of 15 jug of PHA in a 1 ml tissue culture volume.
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Candida albicans pronase-digested mannan was prepared by-
dissolving 2.5 mg of the PDM in 2 ml of RPMI 1640 medium to give
a 50 x stock containing 1.25 mg/ml. Then, 1 ml of this
solution was added to 24 ml of RPMI 1640 medium. Finally,
0.5 ml of this 2 x stock solution was added to 0.5 ml of a
lymphocyte suspension in RPMI 1640 medium in a 13 x 100 mm
glass screw cap culture tube to give a final antigen dose
of 25 jug/ml.
The candidal soluble proteins were diluted for use in a
similar manner to the Candida mannan. About k mg of candidal
proteins were dissolved in 25 ml of RPMI 1640 medium prior to
filter sterilization. This 50 x stock solution, contained
31^ protein, therefore 1.25 mg of protein was contained in
4.05 mg of powder. Then 0.5 ml of this solution was added to
0.5 ml of a lymphocyte suspension in RPMI 1640 medium combined
in a tissue culture tube to give a final antigen dose of 25 ug/
ml.
The final ribosome dose for the tissue cultures
receiving this antigen was 25 ug/ml of RNA. and approximately
22 ug of protein. Since the ribosomes were particulate, this
antigen was added without further filtration. The final
antigen dose for the formalinized whole yeast cells was also
25 /ig/ml in the tissue culture preparations.
Peptidoglucomannan (a soluble polysaccharide) was
extracted from cell wall of Candida albicans with ice cold
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alkali (Reiss jet al. 197*0. It was obtained from the
inventory of fungus extracts maintained by the Mycology
Division, CDC.
8. Constitution of Tissue Culture and Incubation Conditions
The mouse spleen cells were counted in a hemocytometer
and serial dilutions were prepared in 0.5$ trypan blue which
is permeable to dead cells but excluded by living cells. By
using this dye exclusion technique the per cent viability of
splenic lymphocytes was determined. A sufficient quantity of
cells from each suspension was dissolved in RPMI 16*K) medium
to give a final desired concentration of 1 x 10 live cells/
ml. Each 60 ml bottle containing diluted splenic lymphocyte
suspension was labeled (A, B, C, D, E, and F) according to
the mouse from which the cells came.
The cell suspension from each mouse was dispensed in
0.5 ml amounts in 13 x 100 mm glass screw cap culture tubes.
A total of 18 cultures were usually prepared from each mouse
coded to correspond with the mouse spleen, and dose of the
antigen employed. Cultures were incubated in a 37°C
incubator (Wedco Inc., Silver Spring, Maryland) in a humid
atmosphere containing $% C02 for periods of between 3.75 and
4.75 days as specified for each experiment (Mishell and
Dutton, 1967). All cultures were pulsed with 1 uCi of
tritiated thymidine 18 hr. prior to harvesting cultures as
a means of measuring the recruitment of cells into DKA
synthesis for the lymphocyte transformation assay.
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9. Dosage of the Radioisotope Methyl-^H-thymidine
The radioactive DNA precursor methyl-^H-thymidine was
used for incorporation studies. The isotope was obtained in
1 ml amounts having a total activity of 1 mCi and a specific
activity of 6.7 Ci/mmol. (New England Nuclear Company, Boston,
Mass.). Safety procedures for handling radioisotopes and for
dosimetry were those prescribed by the Radiation Safety
Office, Center for Disease Control, Atlanta, Georgia. In
order to produce the final desired concentration of 1 uCi
of tritiated thymidine per culture, 0.15 ml of the undiluted
solution was aspirated in a 1 ml syringe and transferred to
15 ml of RPMI 16^0 medium giving a concentration of 10 uCi/ml.
Then 0.1 ml of this solution (containing 1 juCi) was added to
each tissue culture 18 hr. prior to harvest.
10. Preparation of the Liquid Scintillation Cocktail
The liquid scintillation cocktail was made from a
concentrated toluene solution of the fluors PPO (2, 5-
diphenyloxazole) and POPOP (l,^-bis-2-(5-phenyloxazolyl)-
benzene) (Liquifluor, New England Nuclear Company, Boston,
Mass.). Since samples contained an alkaline tissue
solubilizer which caused chemiluminescence, glacial acetic
acid was added to the cocktail to prevent this problem. To
make 1.25 liters of cocktail, 53 ml of liquifluor and 3.1 ml
of glacial acetic acid were added to 1195 ml of toluene. A
2 liter erlenmeyer flask with a spin bar was placed on a
magnetic stirring platform and about one half the amount of
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toluene was added to the flask. Liquifluor then was poured
in from a 100 ml graduated cylinder, and glacial acetic acid
was added. Finally, the remaining toluene was used to
quantitatively transfer all traces of liquifluor to the
cocktail.
11 * Harvesting Tissue Cultures and Sample pre?flrfl-Hrm ^
Liquid Scintillation Counting ~
Approximately k ml of ice cold 0.85% sodium chloride was
added to each of the tissue cultures and then vortexed. Then
tubes were centrifuged at 411 x g at 10°C for 15 min. and the
supernates were aspirated with a pasteur pipet connected to
a vacuum trap. Next, 5 ml of chilled 5% trichloroacetic acid
was added to the sedimented cells and vortexed. The tubes
then were centrifuged as described above and the supernates
were collected in a radioactive waste receptacle. About k ml
of methanol was added to the sedimented cells, vortexed, and
centrifuged, and the supernates collected as radioactive
waste. Then 0.5 ml of protosol, an alkaline tissue solubilizer,
(New England Nuclear, Boston, Mass.) was added to each
culture and mildly vortexed. All tubes were incubated in a
56°C water bath for 1 hr. to allow complete solubilization
and quantitatively transferred to labeled counting vials with
a toluene-PPO-POPOP scintillation cocktail. Vials were
placed in a scintillation spectrometer (Searle) and were
monitored for radioactive incorporation of tritiated
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The pronase digestion was carried out for ? hr., and at
various intervals samples were removed to determine the
amount of amino acid release (Table 1). A total of 12.0 mg
of amino acid was released during this digestion period which
was 2.k% of the starting weight. After pronase digestion
the PDM was concentrated from 20 ml to 8 ml by molecular
filtration before it was layered on a DEAE Sephadex column.
2* Antj-gen Purification bv Column Chromatocraphy
A. DEAE-Sephadex Fractionation of Pronase Digested Mannan
Pronase treated mannan (500 mg) was fractionated on
DEAE Sephadex and the column effluent was monitored for
carbohydrate and ultraviolet absorbance. Mannan-containing
fractions were pooled, dialyzed, and lyophilized. The
elution profile of PDM is shown in Figure 1. One major
peak was recovered and the total yield of the fluffy white
product was 180.k mg.
B. Concanavalin A-Sepharose Fraction of Candida
Cytoplasmic Extract
The supernate obtained from a 100,000 x g centrifugation
of Candida albicans homogenate was the source of material
for this preparation. After concentration by (NH.) so
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Table 1. Amino acid released from mannan during pronase
treatment.


































Fractions were monitored for
^S«yaK6 <Jott«d line) with phenol-sulfuric
acid and absorbance (dash line) at 280 nm.
ill^U^T U ^ ld
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precipitation, the candidal extract (200 mg) was fractionated
on concanavalin A-Sepharose to remove mannan polysaccharide.
Column fractions were monitored for protein and ultraviolet
absorbance and those tubes containing protein were pooled,
dialyzed versus phosphate buffered saline, then lyophilized.
The extract then was rechromatographed to assure complete
removal of mannan polysaccharide and the total yield of the
white powder was 82.k mg (Figure 2). The results of carbo
hydrate and protein analyses of the candidal proteins and
pronase-digested mannan after column fractionation are
presented in Table 2.
3. Comparative Ability of Various Sera to Support Mouse
Lymphocyte Cultures
Serum obtained from normal human donors was screened by
the Fungus Serology Laboratory (Center for Disease Control,
Atlanta, Georgia) employing the latex agglutination and
immunodiffusion test (Table 3) for evidence of anti-Candida
antibody. The results indicated that there were two pools
of sera (18^ and 199) which had a negligible response in
the above tests. The ability of the two human sera and the
two fetal calf sera (fetal calf unfiltered and fetal calf
filtered) to support mouse lymphocyte cultures was tested
(Table k).
The difference between filtered and unfiltered fetal
calf sera was that filtered serum was collected aseptically
and passed through a bacterial retentive membrane prior to
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storage whereas unfiltered serum may have contained some
psychrophilic bacteria present in the refrigerator of the
processor. The result was that the fetal calf unfiltered
serum was most suitable for mouse lymphocyte cultures as
shown by the stimulation index (PHA 10 ug, 6.20) in Table 4.
The derivation of the stimulation index expression is given
belowi
40,000 cpm incorporation in presence of antigen
(mean of triplicates)
3»000 cpm incorporation by non-stimulated cultures
(mean of triplicates)
Stimulation index =13.3
One of the human serum pools, 184, was also suitable for
supporting mouse lymphocyte tissue cultures with a stimula
tion index of 16.3 in the presence of 10 ug of PHA. The
remaining fetal calf serum (Reheis filtered) and human serum
199 inhibited mouse splenic lymphocytes. As a result, fetal
calf unfiltered serum was chosen as the serum best suited for
supporting mouse lymphocyte cultures and was used throughout
the remainder of the research period. The reconstituted
basal medium was supplemented with % heat inactivated fetal
calf unfiltered serum. Even though the human serum 184
responded favorably in terms of stimulation indices, later
experiments revealed some non-specific stimulation of splenic
lymphocytes. This experiment was also designed to determine
the degree of non-specific stimulation of lymphocyte























Table 2. Protein and carbohydrate composition of pronase-
digested maiman and candidal protein antigens.
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between lymphocyte responses of infected and non-infected
mice could be made. Ten AKR/j mice (6 months-old) were
employed and splenic lymphocytes were reconstituted in
culture for 4 days. Four serum supplements were used
including human serum 199» human serum 184, fetal calf serum,
filtered, and fetal calf unfiltered. Additions to the
medium were Candida pronase-digested mannan, 25 ugj PHA, 10,
25, and 50 ug; and Candida proteins, 25 ug. An antifungal
antibiotic, amphotericin B, (2 ug/ml) was added to the basal
tissue culture medium in addition to penicillin and strepto
mycin. The final concentration of mouse splenic lymphocytes
was 1 X 10 cells/ml/culture.
The results indicated (Table 4) that the splenic
lymphocytes of non-sensitized mice were not stimulated by
the antigens tested. Fetal calf serum unfiltered and human
serum 184 supported good responses to PHA (at 10, 25, and
50 ug doses) and indicated that these sera were appropriate
supplements for mouse splenic lymphocyte cultures. Human
serum 199 showed some ability to support mouse lymphocyte
cultures in the presence of PHA, at 10 and 25 ug doses (S.I.
5»75 and 3*60), but the counts per minute (cpm) for PHA
with this serum supplement were lower than those of other
supplements. Splenic lymphocytes receiving fetal calf serum
filtered showed the least ability to support mouse lymphocyte
cultures from non-sensitized mice.
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4. Lymphocyte Transformation in Mice Injected With Live
Candida albicans Yeast
The objectives of the following experiments were to
sensitize mice with live Candida albicans yeast cells and
to make short-term tissue cultures from splenic lymphocytes
in the presence of antigen or mitogen. After pulsing the
cultures with methyl-^H-thymidine, cultures were harvested
for the measurement of lymphocyte transformation. The
degree of transformation was expressed as the stimulation
index of each culture under various conditions with respect
to the incorporation obtained with non-stimulated control
cultures.
The strain of mice used in this research was AKR/j.
This inbred strain of mice has a high incidence of spontaneous
leukemia with an onset at an average age of 8.8 months. The
mice were received from Jackson Laboratories (Bar Harbor,
Maine) and at various intervals (6-9 months) were injected
with live Candida albicans 3181A yeast cells. In one
experiment, White Swiss mice were sensitized with Candida
albicans 3181A. The mice were approximately 3 months of age
and are an outbred strain maintained for research purposes at
the Center for Disease Control, Atlanta, Georgia.
In the first experiment, (Table 5), mice were 6 months
old AKR/J. Six mice were sensitized with 1 x 10^ live
Candida albicans 3181A yeast cells by intravenous injection
in the tail vein. After a period of 21 days, mice were
sacrificed and splenic lymphocytes were reconstituted in
culture for 3.75 days. Additions to the tissue culture
medium (RPMI 1640) were Candida proteins. 15 ug; Candida
pronase digested mannan. 25 ug; and peptidoglucomannan (PGM),
25 pg. Amphotericin B, an antifungal antibiotic, was added
to the basal tissue culture medium in addition to penicillin
(50 ug/ml) and streptomycin (100 ug/ml). The final concentra
tion of mouse splenic lymphocytes in this experiment was
1 x 10 cells/ml/culture.
The mean stimulation index for PHA in Table 5 was 7.01
which indicated good survival of cells in culture after 3.75
days of incubation. The mean stimulation index for mannan
(1.22) showed a modest degree of transformation compared with
the above stimulation of PHA. The response to PGM (1.05)
was comparatively poor. Cultures from mice A, B, and C were
not stimulated by PGM.
Next (Table 6) 7 months-old AKR/j were employed for
lymphocyte transformation studies. A group of 6 mice were
sensitized with 1 x 104 live Candida albicans 3I8IA yeast
cells. After 21 days mice were sacrificed and splenic
lymphocytes were reconstituted in culture for 3.75 days.
Additions to the tissue culture were Candida pronase-digested
mannan, 25 ug; candidal proteins, 15 ug; and PGM 25 ug.
Amphotericin B was also used in addition to penicillin
(50 ug/ml) and streptomycin (100 ug/ml). The final concentra
tion of mouse splenic lymphocytes in this experiment was 1 x
Table 5« Lymphocyte transformation responses of 6 months-
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Table 6. Lymphocyte transformation responses of 7 months-old mice
L
sensitized with 1 X 10 live Candida albicans yeast cells.
Additions to the
tissue cultures
Stimulation indices of splenic lymphocytes
Mouse




Candidal proteins 25 ug
PGMb
111111
2.93 3.44 2.70 2.49 2.77 2.50
0.80 0.70 1.03 1.00 1.07 1.00
1.14 0.48 0.61 0.98 1.23 0.95
0.83 0.63 0.08 0.82 0.91 1.00
Phytohaemagglutinin 15 pg
Peptidoglucomannan 25 ug
10 cells/ml/culture. The average per cent viability of
mouse splenic lymphocytes observed in this group was 56%,
The viability of mouse lymphocyte cultures in Table 6
was good as shown by a mean stimulation index with respect
to PHA of 2.81. There was some stimulation in mouse A and
E elicited by Candida proteins. Mannan resulted in some
stimulation in mice C, D, E, and F but not in mice A and B.
Candidal proteins did not stimulate mice B, C, D, and F.
PGM did not stimulate any of the cultures with the exception
of slight stimulation in mouse F.
Eight month-old AKR/j mice were used in the next
experiment (Table 7). Six mice were sensitized with 1 x 104
live Candida albicans ?181A yeast cells by intravenous
injection into the tail vein. After 21 days, the mice were
sacrificed and splenic lymphocytes were reconstituted in
culture for 4.75 days. Additions to the tissue culture
medium (RPMI 1640) were formalinized whole yeast cells of
Candida' 25 W candidal proteins, 15 ug; and PDM 25 ug. Heat-
inactivated fetal calf unfiltered serum and human pool 184
were the sources of serum. As an antifungal antibiotic,
nystatin (2 ug/ml) was added to the basal medium in addition
to penicillin and streptomycin. The final concentration of
mouse splenic lymphocytes for this group was 5 x 105 viable
cells/ml/culture. The average per cent viability to mouse
splenic lymphocytes in this experiment was 61%.
Table 7. Lymphocyte transformation responses of 8 months-old mice sensitized with
1 X 10 live Candida albicans yeast cells.
Additions to the Stimulation indices of splenic lymphocytes
Mouse o
tissue cultures . . k Serum sources




























































Formalinized whole yeast cells 25 ug
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The mean stimulation index with respect to PHA in
cultures containing fetal calf unfiltered serum was 2.46
while the mean stimulation index in the presence of PHA and
human serum 184 was I.65. Candida proteins and formalinized
whole yeast cells elicited slight stimulation in cultures
prepared with fetal calf unfiltered serum in mouse B. The
remaining cultures exposed to the antigens in this group were
not stimulated.
5# Lymphocyte Responses in Mice Sensitized with Candida
albicans Antigens in Complete Freund Adjuvant
Next, in view of the marginal responses of mice injected
with live Candida albicans 3181A yeast, it was important to
find out if the antigens were capable of sensitizing the
mice when given in a depot injection in adjuvant. A dose of
200 pg of Candida proteins or Candida pronase-digested mannan
in complete Preund adjuvant was injected intraperitoneally
and 21 days later the mice were sacrificed and splenic
lymphocytes were reconstituted in tissue cultures along with
the corresponding Candida antigen. The lymphocyte trans
formation responses of 6 mice in the experiment group is
shown in Table 8 with respect to Candida proteins.
The mice employed in this experiment (Table 8) were
AKR/J that were 8.5 months-old. Ten mice were sensitized
with 200 jxg of Candida proteins in complete Freund adjuvant.
Splenic lymphocytes were reconstituted in culture for 4.75
days. Additions to the culture medium (RPMI 1640) were
purified protein derivative of tuberculin (PPD), 20 ug} and
Candida proteins at 5, 15, and 50 ug doses. Heat-inactivated
fetal calf (unfiltered) serum was employed. Nystatin was
included as an antifungal antibiotic. Both antigens, PPD
and Candida proteins, were soluble. The final concentration
of mouse splenic lymphocytes in this experiment was 5 x 10^
live cells/ml/culture. The average per cent viability of
mouse lymphocytes in this group was 54$.
Five out of 6 mice tested responded vigorously to
candidal protein antigen. Mouse B was the best responder
and gave evidence of good stimulation at a dose of 5 ug of
candidal proteins (S.I. = 15.8). The second best responder
to the antigens tested was mouse D (S.I. range 1.56 to 3.19).
The response of mouse lymphocyte cultures towards PHA (mean
S.I. = 5.0) indicated that cell viability in the tissue
culture remained high. The best responder with respect to
PHA was mouse B (S.I. = 16.9) and the poorest responder was
mouse E (1.53). PPD did not elicit stimulation in mice A,
C, and E but did in mice B and D. Apparently the protein
antigen was a potent elicitor of lymphocyte transformation
in mice sensitized with protein in complete Freund adjuvant.
The ability of PDM to act as an antigen in the lymphocyte
transformation assay was also tested employing mice sensitized
with PDM in complete Freund adjuvant. A group of 10 nine-
month old AKR/J mice were sensitized with 200 fxg of Candida
mannan in complete Freund adjuvant by depot injection into
the peritoneal cavity. Six mice were sacrificed after 21 days
Table 8. Lymphocyte transformation responses of 8.2 months-old AKR mice
immunized with candidal proteins in complete Freund adjuvant.
Additions to the
tissue cultures






Candidal proteins 5 ug
Candidal proteins 15 ug
Candidal proteins 50
Phytohaemagglutinin 15
2.36 16.9 2.66 5.65











Purified protein derivative of tuberculin 25 jag
and mouse splenic lymphocytes were reconstituted in culture
for ^»75 days. Additions to the tissue culture medium were
PPD, 15 ug, or Candida PDM at doses of either 5, 10, or 50 ug,
Inactivated fetal calf serum (unfiltered) was also included.
Nystatin, an antifungal antibiotic, was added to the tissue
culture medium as well as penicillin and streptomycin. Each
culture contained 5 x 10^ viable cells/ml/culture and the
average per cent viability for this group was 50$. When mice
were sensitized in complete Freund adjuvant, pronase-digested
mannan of Candida was a good elicitor of lymphocyte
transformation.
In Table 9(b) the mean stimulation index with respect to
PHA for this experiment was 7.03 and the lymphocyte responses
expressed as stimulation indices elicited by Candida pronase-
digested mannan at doses 15 ug and 50 ug were 7.34 and 7.37
respectively. A comparison of all the stimulation indices
in this group showed that mouse D was the best responder
resulting with a stimulation index of 14.1 at a mannan dose
of 15 ug which was the optimal concentration of this antigen.
6» Lymphocyte Transformation Responses of White Swiss Mice
In.iected with Live Candida albicans Yeast
Six 3 month-old White Swiss mice were employed in the
experiment shown in Table 10. These mice were sensitized
by injection into the tail vein with 1 x 10^ live Candida
albicans 3183A yeast cells. After 21 days, mice were
sacrificed and splenic lymphocytes were reconstituted in
50
Table 9(a). Lymphocyte transformation responses of 9 months-
old AKR mice immunized with pronase-digested
























































aCounts/min. in means of triplicates
Phytohaemagglutinin 15 ug
"Turified protein derivative of tuberculin 25 ug
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Table 9(b). Lymphocyte transformation responses of 9 months-
old AKR mice immunized with pronase-digested





Stimulation indices of splenic lymphocytes
Mouse













4.62 11.74 7.61 4.75
2.00 5.80 3.78 1.62
4.98 12.40 8.27 2.80
4.40 14.20 8.73 2.83
3.70 14.0 8.18 2.46
aPhytohaemagglutinin 15 ug
Purified protein derivative of tuberculin 25 ug
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culture for k.?5 days. Additions to the medium were Candida
proteins, 10 pg, Candida PDM 15 ug} Candida cell walls, 25 ug,
and Candida ribosomes, 20 Hg. Inactivated fetal calf serum
(unfiltered) was employed and nystatin was included as an
antifungal antibiotic. The final concentration of mouse
splenic lymphocytes in this experiment was 5 x 105 viable
cells/ml/culture and the average per cent viability of mouse
lymphocytes in this group was kz%. As shown in Table 10,
PHA containing cultures gave rise to good stimulation indices
(S.I. range 1.3 to 8.7) indicating that the cells remained
viable during the tissue culture period. Candida proteins
in mouse C and E and Candida mannan, in mouse B, C, and F
elicited a modest degree of lymphocyte transformation. These
mice did not respond to Candida cell walls and Candida
ribosomes, which were toxic at the doses supplied.
7t The Histopathologioal Picture of Candida albirang
Infection " ' " "—
Histopathological examination of the mice injected with
live Candida albicans 2232A yeast cells indicated that only
a few mice showed signs of Candida albicans in the target
organ, the kidney. In those mice which had kidney infections,
the organism was seen in the pelvis and also in the transitional
epithelial lining of the pelvis. Erosion of the epithelial
lining was noticed and yeast were seen in the collecting
tubules of the medulla resulting in a pyelonephritis. The
tissue response varied from slight to moderate infiltration
Table 10. Lymphocyte transformation responses of 3 months-old







Candidal proteins 25 ug
Mannan 25 ug


















































of inflammatory cells of the polymorphonuclear class.
There were no unusually high white blood cell counts in
the AKR mice (6-9 months-old) and the average range for
the mice employed in each experiment was 8000 wbc/mnr.
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Fig. 3. Pseudohyphae and budding forms of Candida albicans
within renal pelvis on the lower right. Gomorl









Fig. ^. Higher power of Figure 3 demonstrating "typical
pseudohyphae and elongated buds of Candida albicans
within the renal pelvis. G-M-Sj X 675
CHAPTER V
DISCUSSION AND CONCLUSIONS
1# The AKR Mouse as a Model for Candida albicans
The inbred AKR/j mouse employed in this research develop
spontaneous leukemia at an average age of 8.8 months (Gross,
1970). The breeder, Jackson Laboratories, Bar Harbor, Maine,
supply on 6 months-old animals and therefore, the mice were
aged before injection of live C. albicans yeast cells. None
of the mice tested developed leukemia, even at 9 months-old.
The average white blood cell count of AKR mice obtained in
this research was 8000 wbc/mm3. No unusually high counts
were observed and is recommended that mice be monitored at
9. 10, 11, and 12 months of age in order to superimpose a
Candida albicans infection on the mice in a leukemic state.
The average white blood cell count for the leukemic AKR mouse
as reported by Gross (1970) was 55.000 wbc/mm3.
2# Indication of Delayed-type HvpersensitivitY
The method employed for inducing delayed type hyper
sensitivity was the injection into the tail vein of 1 x 10^
live Candida albicans yeast cells. In those mice receiving
Candida pronase-digested mannan or candidal proteins (200 ;*g)
in adjuvant, the method of choice for inducing delayed type
hypersensitivity was a depot injection into the peritoneal
cavity. Several suggestions are pertinent to further studies
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of the lymphocyte transformation responses to Candida
albicans infection in mice. The time interval after
injection of live C. albicans until the spleen cells are
removed and tested is a variable worthy of further
examination. Three weeks, the interval used in the present
work may not have been long enough and perhaps 4, 5, or 6
weeks post-infection would raise the stimulation indices to
more significant levels. The dose and route of infection
are also important. It is suggested that larger infective
k
doses than 1 x 10 live yeast cells should be tested,
possibly injecting via the intraperitonal route to minimize
risks of early mortality. Then mice could be kept for longer
intervals of time to allow full maturation of delayed
hypersensitivity. Before attempting lymphocyte transformation
tests, it is recommended that mouse foot pad swelling test
(Crowle, 1975) be employed to screen mice in a non-destructive
experiment for their level of delayed-type hypersensitivity.
In this way, it would be possible to retest mice at weekly
intervals until the foot pad responses reach a plateau.
3. Optimal Conditions for Tissue Culture
It was necessary to establish an optimal set of
conditions for culturing mouse spleen cells. The choice of
medium for supporting cultures prepared from mouse splenic
lymphocytes was extremely important, because lymphocyte
cultures must not only survive the culture periods of 4-5
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days but must also maintain their ability to respond to
antigens and undergo blast transformation. Eagles Minimal
Essential Medium (MEM) employed during the initial stages
of this research and prepared by the Media Laboratory,
Center for Disease Control, gave variable splenic lymphocyte
responses to the mitogen phytohaemagglutinin indicating low
viability. Another medium, RPMI 1640, was also employed in
the base line studies in comparison with Eagles MEM for
maintaining viable tissue cultures. The RPMI 1640 medium
contained 200 mg/liter less sodium bicarbonate and appeared
to enhance lymphocyte viability. In each case, it was
necessary to allow the medium to reach room temperature,
about 23°C, before stable adjustment of pH could be attained
to the desired pH of 7.3. It was also considered dssirable
to check the osmolarity of the reconstituted medium. The
mouse blood osmolarity of 308 milliosmoles was closely matched
by reconstituted RPMI medium of 298 milliosmoles. Cultures
maintained for 4-5 days received 0.1 ml of fresh medium as a
supplement every other day.
Another important aspect in this research was the need to
prevent mouse splenic lymphocytes from clumping after
preparing the lymphocyte suspension. Centrifuge speed and
temperature were closely monitored because these elements
can effect cell viability as well as cause clumping. Measures
were taken to minimize clumping by restricting centrifuge
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speed to not more than 411 x g (1200 rpm), by maintaining a
temperature of not less than 5°C and preferably 10°c, and
by limiting the centrifugation time to 30 min. or less. The
maximum recovery of mouse splenic lymphocytes is 1 x 108 cells/
spleen. In this study the average recovery was 2 x 10? cell/
spleen and per cent viability was measured by trypan blue dye
exclusion. It was not determined if the red cell lysing
fluid was injurious to the lymphocytes to the extent of
lowering the per cent viability. Over-exposure to ammonium
chloride, one of the components of the red blood cell lysing
fluid, could have reduced the number of viable cells and
therefore the splenic lymphocyte suspension was allowed only
5 min. to react at room temperature. It was obvious after
this time that red cell lysis had occurred due to the red
color of the suspending fluid.
A review of the literature (Kirkpatrick et al. I971)
pertinent to this research has revealed that conditions for
tissue culture incubation vary with the laboratory in which
the experiment is being performed. For the present, the
optimum incubation time for lymphocyte transformation was
4.75 days. The cell concentration of 5 x 105 viable cells
was considered optimal. No bacterial or fungus contamination
of these cultures occurred in the presence of penicillin,
streptomycin and nystatin, all of which should be included in
further studies. The optimum dose of antigen appeared to be
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25 pg or less and for phytohaemagglutinin 15 ug/ml was
sufficient.
In summary, this study indicated that the optimal
conditions of tissue culture should include the use of RPMI
164-0 medium; an incubation time of 4-5 days; the addition
of penicillin and streptomycin and an antifungal antibiotic
if live yeast is injected into animalst an antigen dose of
25 ugj the addition of 0.1 ml of fresh medium every other
day; incubation of tissue cultures in a % C02 water saturated
atmosphere and a lymphocyte concentration of 5 x 10^ viable
cells/ml/culture.
^« Antigenicitv of Extracts of Candida albicans as
Elicitors of Lymphocyte Transformation
Of the antigens tested, candidal proteins and Candida
pronase-digested mannan (25 fig) were good elicitors of
lymphocyte transformation in mouse spleen cells of AKR mice
injected with antigen in complete Freund adjuvant (Tables 8
and 9). Those mice receiving a depot injection of Candida
pronase-digested mannan in adjuvant responded more vigorously
than the mice receiving a depot injection of candidal proteins
in adjuvant. Candida pronase-digested mannan was potent enough
to elicit lymphocyte transformation (Table 9) with a dose as
small as 5 ug, but the stimulation indices varied from mouse
to mouse. In Table 8, candidal protein doses of 5 and 15 ug
were sufficiently potent to elicit lymphocyte transformation,
however, at a dose of 50 jug of candidal proteins toxicity
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began to occur. The splenic lymphocytes from mouse B in this
group gave the best response to the candidal protein antigen.
The Candida ribosome preparation appeared to be toxic
to the mouse lymphocytes at the dose supplied as 25 ug RNA and
20 ug ribosomal protein. Traces of Triton x 100 detergent in
the ribosome pellets may have rendered this antigen toxic to
mouse lymphocyte cultures. The presence of Triton is
important in view of the ability of antigens derived from
Histoplasma capsulatum to confer protection in mice against
subsequent challenge with live yeast forms (Feit and Tewari,
1974).
5. Prospects for Future Extension of Lymphocyte Transformation
Assay to Measure Human Host Resistance to Candida albicans
Infection
The lymphocyte transformation assay is an acceptable
method for studying cell mediated immunity .in vitro, but
requires more intensive development in the Candida albicans
infected mouse system with respect to the choice of antigens
to be tested, the route and schedule of sensitization and
the dosimetry of the antigen for tissue culture. The various
Candida albicans subcellular fractions such as mannan,
cytoplasmic proteins and ribosomes still need further
evaluation in the lymphocyte transformation assay of infected
mice. Then human peripheral blood lymphocytes could be
evaluated in a lymphocyte transformation assay with Candida
albicans subcellular fractions. Such a test would give an
index of host-resistance to Candida albicans infection.
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The ability of human lymphocytes to mount a vigorous
transformation in the presence of Candida antigen would
indicate a successful ability to combat this yeast infection.
Consequently, a poor response would alert the physician to
the possibility that the patient is vulnerable to
candidiasis, such as a leukemic in relapse (Kirkpatrick,
Rich and Bennett, 1971). Close monitoring of such an




Six to nine month-old AKR mice were injected intra
venously with 1 x 10^ live Candida albicans yeast cells in
an attempt to superimpose C. albicans infection on the mice
in a leukemic state. After 21 days post-infection the mice
were sacrificed and tissue cultures were prepared in triplicates
from mouse splenic lymphocytes. Test antigens were prepared
from Candida albicans extracts and added to the reconstituted
tissue cultures which were incubated for 4.75 days. Eighteen
hr. prior to harvest each culture was pulsed with 1 uCi of
tritiated thymidine.
The degree of blast transformation of mouse splenic
lymphocytes was determined by incorporation of tritiated
thymidine during DNA synthesis of mouse lymphocyte cultures.
The results of the lymphocyte transformation assay indicated
that Candida pronase-digested mannan and candidal soluble
proteins were good elicitors of lymphocyte transformation when
given in a depot injection in complete Freund adjuvant.
Candidal soluble proteins and pronase-digested mannan of
C. albicans also showed marginal ability to elicit lymphocyte
transformation in infected mice. It is hoped that the
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lymphocyte transformation assay with a leukemic mouse model
will be used to further investigate the cellular immune
response in infections with Candida albicans.
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